Search results
Results from the WOW.Com Content Network
The Chief Scientific Officer in England is the head of profession for the 53,000 healthcare scientists working in the National Health Service and its associated bodies.. The Chief Scientific Officer is one of the NHS professional officers (including the National Medical Director and Chief Nursing Officer) who are employed within NHS England.
NHSBSA administers the NHS Pension Scheme in England and Wales, offering services for members, employers and surviving spouses, partners or dependants. Scanning services digitise medical records from across the NHS. NHSBSA also took on NHS Jobs, the official online recruitment service for the NHS in England and Wales on 1 April 2018.
The document, building on the 2006 Best Research for Best Health strategy, outlined the updated operational principles, core work-streams and areas of strategic focus of the NIHR. [25] Their work-streams include funding research for the NHS, public and global health and social care ; investing in expertise and facilities; and involving patients ...
The department was established on 7 February 2023 after a cabinet reshuffle by Prime Minister Rishi Sunak.It absorbed some of the functions and responsibilities of the former Department for Business, Energy and Industrial Strategy (BEIS) and the 'Digital' portfolio from the former Department for Digital, Culture, Media and Sport (DCMS).
The MHRA is divided into three main centres: [citation needed] MHRA Regulatory – the regulator for the pharmaceutical and medical devices industries; Clinical Practice Research Datalink – licences anonymised health care data to pharmaceutical companies, academics and other regulators for research
A biomedical scientist is a scientist trained in biology, particularly in the context of medical laboratory sciences or laboratory medicine.These scientists work to gain knowledge on the main principles of how the human body works and to find new ways to cure or treat disease by developing advanced diagnostic tools or new therapeutic strategies.
Red or healthcare biotechnology is the application of biotechnology for the production of medicines and therapies. EuropaBio's stated goals are: promoting an innovative, coherent, and dynamic biotechnology-based industry in Europe; advocating free and open markets and the removal of barriers to competitiveness with other areas of the world;
Around £920m is spent on biotechnology research in the UK, around 4.5% of all private sector research and development. According to an OECD study, the UK is fourth in the world for expenditure on biotechnology research, after the USA, France and Switzerland. France spends around twice that of the UK on biotechnology.